DE60126994D1 - Stabilisierung von radiopharmazeutischen zusammensetzungen mit einem hydrophilen thioether oder einem hydrophilen 6-hydroxy-chroman - Google Patents

Stabilisierung von radiopharmazeutischen zusammensetzungen mit einem hydrophilen thioether oder einem hydrophilen 6-hydroxy-chroman

Info

Publication number
DE60126994D1
DE60126994D1 DE60126994T DE60126994T DE60126994D1 DE 60126994 D1 DE60126994 D1 DE 60126994D1 DE 60126994 T DE60126994 T DE 60126994T DE 60126994 T DE60126994 T DE 60126994T DE 60126994 D1 DE60126994 D1 DE 60126994D1
Authority
DE
Germany
Prior art keywords
hydrophilic
hydroxy
compositions
thioetherant
hydrophilene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60126994T
Other languages
English (en)
Other versions
DE60126994T2 (de
Inventor
John E Cyr
Daniel A Pearson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CIS Bio International SA
Original Assignee
CIS Bio International SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CIS Bio International SA filed Critical CIS Bio International SA
Publication of DE60126994D1 publication Critical patent/DE60126994D1/de
Application granted granted Critical
Publication of DE60126994T2 publication Critical patent/DE60126994T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physics & Mathematics (AREA)
  • Dispersion Chemistry (AREA)
  • Epidemiology (AREA)
  • Optics & Photonics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE60126994T 2000-10-24 2001-10-24 Stabilisierung von radiopharmazeutischen zusammensetzungen mit einem hydrophilen thioether oder einem hydrophilen 6-hydroxy-chroman Expired - Lifetime DE60126994T2 (de)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US695494 1976-06-14
US69499200A 2000-10-24 2000-10-24
US69536000A 2000-10-24 2000-10-24
US69549400A 2000-10-24 2000-10-24
US695360 2000-10-24
US694992 2000-10-24
PCT/US2001/050423 WO2002060491A2 (en) 2000-10-24 2001-10-24 Stabilization of radiopharmaceutical compositions using a hydrophilic thioether or a hydrophilic 6-hydroxy chroman

Publications (2)

Publication Number Publication Date
DE60126994D1 true DE60126994D1 (de) 2007-04-12
DE60126994T2 DE60126994T2 (de) 2007-11-15

Family

ID=27418608

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60126994T Expired - Lifetime DE60126994T2 (de) 2000-10-24 2001-10-24 Stabilisierung von radiopharmazeutischen zusammensetzungen mit einem hydrophilen thioether oder einem hydrophilen 6-hydroxy-chroman

Country Status (12)

Country Link
US (1) US20040058984A1 (de)
EP (2) EP1381397B1 (de)
JP (1) JP4236468B2 (de)
AT (1) ATE355087T1 (de)
AU (1) AU2002249863A1 (de)
CA (1) CA2426587A1 (de)
CY (1) CY1106622T1 (de)
DE (1) DE60126994T2 (de)
DK (1) DK1381397T3 (de)
ES (1) ES2282326T3 (de)
PT (1) PT1381397E (de)
WO (1) WO2002060491A2 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050090551A1 (en) * 2003-10-27 2005-04-28 Board Of Trustees Of Southern Illinois University Therapeutic use of methionine for the treatment or prevention of mucositis
PL2220030T3 (pl) * 2007-11-06 2016-07-29 Bioelectron Tech Corp Pochodne 4-(p-chinonylo)-2-hydroksybutanamidu do leczenia chorób mitochondrialnych
KR20110076918A (ko) * 2008-09-10 2011-07-06 제넨테크, 인크. 단백질의 산화성 분해를 방지하기 위한 조성물 및 방법
US20130217908A1 (en) * 2010-10-28 2013-08-22 Ge Healthcare Limited Stabilisation of radiopharmaceutical precursors
DK2694095T3 (en) 2011-04-05 2018-05-28 Longevity Biotech Inc COMPOSITIONS COMPREHENSIVE GLUCAGON ANALOGS AND METHODS FOR PREPARING AND USING THE SAME
WO2014145718A2 (en) 2013-03-15 2014-09-18 Longevity Biotech, Inc. Peptides comprising non-natural amino acids and methods of making and using the same
US10053499B2 (en) 2013-03-29 2018-08-21 Glytech, Inc. Polypeptide having sialylated sugar chains attached thereto
EP3525821A4 (de) 2016-10-17 2020-09-09 University of Maryland Multispezifische antikörper gegen das humane immundefizienz-virus und verfahren zu deren verwendung
US11142553B2 (en) 2016-11-29 2021-10-12 Spiber Inc. Protein composition, method for producing same and method for improving heat stability

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3476772A (en) * 1966-10-20 1969-11-04 Eastman Kodak Co Chroman derivatives of 2,5-dimethyl-2,4-hexadiene
US3986980A (en) * 1974-04-29 1976-10-19 Hoffmann-La Roche Inc. Synergistic antioxidant composition comprising ascorbic acid and 6-hydroxy-2,5,7,8-tetramethylchroman-2- carboxylic acid
JPS6094976A (ja) * 1983-10-28 1985-05-28 Sumitomo Chem Co Ltd クロマン誘導体およびその製造方法
US5393512A (en) * 1985-01-14 1995-02-28 Vanderheyden; Jean-Luc Stable therapeutic radionuclide compositions and methods for preparation thereof
US6030950A (en) * 1987-07-09 2000-02-29 Ohlenschlaeger; Gerhard Pharmaceutical therapeutic use of glutathione derivative
DE3722647A1 (de) * 1987-07-09 1989-01-19 Gerhard Ohlenschlaeger Galenische verwendung eines tripeptids als arzneimittel
US5759515A (en) * 1989-08-09 1998-06-02 Rhomed Incorporated Polyvalent peptide pharmaceutical applications
AU2541592A (en) * 1991-08-01 1993-03-02 Hybritech Incorporated Improvements in or relating to modified haptens useful as imaging and therapeutic agents
JPH06228170A (ja) * 1993-02-04 1994-08-16 Noda Sangyo Kagaku Kenkyusho ホスファチジルクロマノール誘導体、その製造方法、抗酸化剤及び乳化剤
JP3051591B2 (ja) * 1993-03-05 2000-06-12 日本メジフィジックス株式会社 タリウム−201の容器に対する付着防止剤
JP3839071B2 (ja) * 1993-12-07 2006-11-01 有限会社ケムフィズ クロマン誘導体
TW486499B (en) * 1997-10-02 2002-05-11 Yoshitomi Fine Chemicals Ltd A stabilizer composition containing 6-hydroxy compound for organic polymer material and an organic polymer composition
EP0955355A3 (de) * 1998-04-28 2000-08-02 Ciba SC Holding AG Antioxidantien zur Stabilisierung tensidhaltiger Formulierungen
US6171578B1 (en) * 1999-04-14 2001-01-09 Diatide, Inc. Benzodiazepine derivatives for imaging thrombi

Also Published As

Publication number Publication date
DK1381397T3 (da) 2007-06-18
CY1106622T1 (el) 2012-01-25
EP1808184A3 (de) 2008-08-13
AU2002249863A1 (en) 2002-08-12
EP1381397B1 (de) 2007-02-28
US20040058984A1 (en) 2004-03-25
ES2282326T3 (es) 2007-10-16
EP1381397A2 (de) 2004-01-21
JP4236468B2 (ja) 2009-03-11
JP2005500982A (ja) 2005-01-13
PT1381397E (pt) 2007-05-31
WO2002060491A3 (en) 2003-11-06
ATE355087T1 (de) 2006-03-15
WO2002060491A2 (en) 2002-08-08
DE60126994T2 (de) 2007-11-15
CA2426587A1 (en) 2002-08-08
EP1808184A2 (de) 2007-07-18

Similar Documents

Publication Publication Date Title
DE60235900D1 (de) Osuppressivum
DK0897904T3 (da) Fungicide 2-methoxybenzophenoner
DE69739968D1 (de) Erythropoietin-Lösungszubereitung, stabilisiert mit Leucin oder Glutaminsäure
DE59800046D1 (de) Stabilisierung von naloxonhydrochlorid
NL1002835A1 (nl) Synergistisch stabilisatormengsel.
BRPI0317696B8 (pt) composição para branqueamento
IL163911A0 (en) Naltrexone hydrochloride compositions
DK1454138T3 (da) Immunocytokiner med moduleret selektivitet
ES2176212T3 (es) Eteres de fosfonooximetilicos o metiltiometilicos de derivados de taxano como agentes antitumorales.
HK1046004A1 (en) Recombinant gelatins
GEP20104997B (en) Composition comprising anther2 antibodies
ES2128024T3 (es) Estabilizacion de fibra pigmentada con una mezcla sinergistica de amina impedida y absorbedor de uv.
CY1107272T1 (el) Παραγωγο διαρυλ σουλφιδιου, αλας προσθηκης εξ αυτου και ανοσοκατασταλτικο
BR0313342A (pt) Método de preparação de compostos
DK1385514T5 (da) Spiroinden- og spiroindanforbindelser
MXPA05013251A (es) Composiciones para estado de oxigeno mejorado en animales de compania.
NO942899L (no) Stabiliserte, radiofarmasöytiske sett
CY1106622T1 (el) Σταθεροποιηση ραδιοφαρμακευτικων συνθεσεων χρησιμοποιωντας υδροφιλικους θειοαιθερες και υδροφιλικες 6-υδροξυ χρωμανες
DE60117467D1 (de) Famotidin-injektionen
ATE425140T1 (de) Mercaptane und disulfide
HUT57820A (en) Process for stabilizing 3-isothiazolones with mexamethylene tetraamine, stabilized compositions and process for utilizing them
ATE103166T1 (de) Haarbehandlungszusammensetzung.
BR0206424B1 (pt) emulsão estabilizada reversìvel e processo de controle da estabilização de uma emulsão reversìvel.
ATE391489T1 (de) Haarbehandlungszusammensetzungen
BR0210731A (pt) Uso de ácidos fluoralcanossulfÈnicos para estabilizar plásticos orgânicos contendo halogênio

Legal Events

Date Code Title Description
8328 Change in the person/name/address of the agent

Representative=s name: DF-MP, 80333 MUENCHEN

8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: KLOSE, W., DIPL.-CHEM. DR.RER.NAT., PAT.-ANW., 135